Nitrofurazone

呋喃西林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNitrofurazone
Drug Alias NameNitrofural硝基糠腙Furacilin硝化富乐逊呋喃新 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate synthase inhibitors
TargetsPyruvate synthase
Therapy Area/IndicationsBurnsHemorrhageDermatitis +[5] 
Global Approved IndicationsBurnsDermatitisDacryocystitis
Approved Indications in ChinaBurnsDermatitisDacryocystitis
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Jiu'An Pharmaceutical Co LtdHuangshi Yanwu Pharmaceutical Co Ltd
Inactive CompaniesHainan Huanglong Pharmaceutical Factory Co Ltd
Active IndicationsBurnsHemorrhageDermatitis +[4] 
Inactive IndicationsSkin Diseases, Bacterial

Other Information

ATC CodeB05CA03D08AF01D09AA03 +[6] 
Related LinksWikipediaDrugBankKEGG